Takeda has been named a Top Employer in 2021 in the Middle East for the second consecutive year by Top Employers Institute. This is also the fourth year in a row Takeda has received the prestigious global Top Employer® status.

Further to Saudi Arabia and the United Arab Emirates in the Middle East, Takeda also received regional certifications for Asia Pacific, Europe and Latin America, with India, Ukraine, Kazakhstan, Algeria and Turkey also being similarly awarded. 38 Takeda local operating companies were accredited this year around the world.

Dr. Mahender Nayak, Area Head for ICMEA (India, C.I.S., Middle East, Turkey, and Africa) at Takeda said, “Our team is the cornerstone of our long-term growth strategy that seeks to drive positive patient outcomes. By creating an exceptional people experience we are committed to maintain a vibrant, diverse and inclusive workplace that provides opportunities for everyone and where the health and well-being and career development of is a priority.”

“We are delighted to be named as Top Employer in the Middle East for the second consecutive year. We credit the award to our success in embracing diversity, and fostering a culture of trust that is helping us create better health for people and a brighter future for the world. We are committed to being a patient-centric and customer-centric organization where people can thrive, grow and realize their full potential,” added Rodrigo Rodriguez, General Manager at Takeda Pharmaceuticals in the Middle East.

Top Employers Institute CEO David Plink commented, “Takeda continues to show its dedication to its employees globally and locally, and we congratulate them for the fourth year in a row of global Top Employer certification.”

The Top Employers Institute program certifies organizations based on the participation and results of their HR Best Practices Survey. This survey covers six HR domains consisting of 20 people-centric topics such as Career Development, Culture, Diversity & Inclusion, Learning, Sustainability, Values, Well-being and Work Environment. Established 30 years ago, the Institute has certified more than 1,600 Top Employers across five continents.

To learn more about Top Employers Institute and the Top Employers certification please visit: www.top-employers.com

About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries. For more information, visit https://www.takeda.com

Media contacts
Stephanie Khoury
Senior Account Executive
FleishmanHillard
stephanie.khoury@fleishman.com 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.